Less is more: Self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells
Description
In the last few years, mRNA therapeutics experienced a new wave of interest as therapy for retinal diseases. Nevertheless, despite the widespread use of mRNA vaccines in the COVID-19 pandemic, mRNA delivery to the eye is still in its infancy
